Lifemd Inc Stock Fundamentals
| LFMD Stock | USD 6.36 0.02 0.32% |
LifeMD Inc fundamentals help investors to digest information that contributes to LifeMD's financial success or failures. It also enables traders to predict the movement of LifeMD Stock. The fundamental analysis module provides a way to measure LifeMD's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LifeMD stock.
At present, LifeMD's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 54.3 M, whereas EBIT is forecasted to decline to (15.6 M). LifeMD | Select Account or Indicator |
LifeMD Inc Company Return On Asset Analysis
LifeMD's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current LifeMD Return On Asset | -0.21 |
Most of LifeMD's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LifeMD Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
LifeMD Total Assets
Total Assets |
|
Based on the latest financial disclosure, LifeMD Inc has a Return On Asset of -0.2134. This is 97.56% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 52.43% higher than that of the company.
LifeMD Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LifeMD's current stock value. Our valuation model uses many indicators to compare LifeMD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LifeMD competition to find correlations between indicators driving LifeMD's intrinsic value. More Info.LifeMD Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, LifeMD's Return On Equity is projected to drop based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value LifeMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.LifeMD Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LifeMD's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LifeMD could also be used in its relative valuation, which is a method of valuing LifeMD by comparing valuation metrics of similar companies.LifeMD is currently under evaluation in return on asset category among its peers.
LifeMD ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, LifeMD's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to LifeMD's managers, analysts, and investors.Environmental | Governance | Social |
LifeMD Fundamentals
| Return On Equity | -7.82 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 263.02 M | ||||
| Shares Outstanding | 43.31 M | ||||
| Shares Owned By Insiders | 15.57 % | ||||
| Shares Owned By Institutions | 40.50 % | ||||
| Number Of Shares Shorted | 5.87 M | ||||
| Price To Book | 107.72 X | ||||
| Price To Sales | 1.43 X | ||||
| Revenue | 152.55 M | ||||
| Gross Profit | 100.37 M | ||||
| EBITDA | (8.21 M) | ||||
| Net Income | (20.6 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 18.93 M | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | (0.18) X | ||||
| Cash Flow From Operations | 8.82 M | ||||
| Short Ratio | 8.92 X | ||||
| Earnings Per Share | (0.64) X | ||||
| Target Price | 12.71 | ||||
| Number Of Employees | 207 | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 275.46 M | ||||
| Total Asset | 58.48 M | ||||
| Retained Earnings | (214.27 M) | ||||
| Working Capital | 7.82 M | ||||
| Net Asset | 58.48 M |
About LifeMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LifeMD Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LifeMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LifeMD Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 8.8 M | 9.3 M | |
| Total Revenue | 152.5 M | 160.2 M | |
| Cost Of Revenue | 18.9 M | 19.8 M | |
| Stock Based Compensation To Revenue | 0.08 | 0.08 | |
| Sales General And Administrative To Revenue | 0.34 | 0.32 | |
| Research And Ddevelopement To Revenue | 0.04 | 0.04 | |
| Capex To Revenue | 0.06 | 0.04 | |
| Revenue Per Share | 4.50 | 4.72 | |
| Ebit Per Revenue | (0.09) | (0.10) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out LifeMD Piotroski F Score and LifeMD Altman Z Score analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 4.847 | Quarterly Revenue Growth 0.383 | Return On Assets (0.21) | Return On Equity (7.82) |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.